A Phase II Study designed to evaluate the efficacy of Chemo-Radiotherapy in achieving
loco-regional control in patients with Merkel Cell Carcinoma (MCC) of the skin. Patients will
undergo PET scans to assist in staging and planning the patient's treatment as well as
assessing response at the conclusion of treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group Trans-Tasman Radiation Oncology Group (TROG)